Precision BioSciences, Inc. (DTIL) vs Inogen, Inc. (INGN)

A side-by-side comparison of Precision BioSciences, Inc. and Inogen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DTIL vs INGN

growth of $100 · dividends reinvested · last 8y
DTIL -98.8% (-42.4%/yr)INGN -93.5% (-29.0%/yr)INGN compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$1$6
DTIL INGN

DTIL vs INGN: by the numbers

  • •DTIL is the larger company ($171M vs $156M market cap).
  • •Both run net losses; INGN's is the smaller (-6.94% vs -117.04% net margin).
  • •DTIL grew revenue faster over the past five years (7.13% vs 1.02% CAGR).

Metrics side by side

Valuation

MetricDTILINGN
P/S ratio3.800.44
P/B ratio3.780.89

Profitability

MetricDTILINGN
Gross margin100.00%48.89%
Operating margin-152.19%-8.45%
Net margin-117.04%-6.94%
ROE-116.42%-14.07%
ROIC-30.23%-13.94%

Growth (annualized)

MetricDTILINGN
Revenue CAGR (5Y)7.13%1.02%
Total return CAGR (5Y)-54.84%-32.83%

Frequently asked

Which has grown faster, DTIL or INGN?
Over the past five years, DTIL grew revenue faster — DTIL at a 7.13% CAGR versus INGN at 1.02%.
How have DTIL and INGN total returns compared?
Over the past 5 years, DTIL delivered -54.84% and INGN delivered -32.83% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.